Endocan or endothelial cell-specific molecule-1: A novel prognostic marker of sepsis?

Critical Care Medicine

Volumn 34, Issue 2, 2006, Pages 574-575

  Filep, János G ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Endocan (endothelial cell specific molecule 1); Endothelial dysfunction; Prognosis of sepsis; Sepsis

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PROCALCITONIN;

CELL ACTIVATION; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIUM CELL; HUMAN; INTENSIVE CARE UNIT; KIDNEY; LUNG; LUNG CARCINOMA; MEDICAL LITERATURE; MOLECULAR DYNAMICS; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SURVIVAL;

EID: 31344470357     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000199054.13823.A7     Document Type: Editorial

References (9)

1. Parillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1991; 328:1471-1477
2. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nature Med 2003; 9:517-524
3. Marshall JC: Such stuffs as dreams are made on: Mediator-directed therapy in sepsis. Nature Rev Drug Discovery 2003; 2:391-405
4. Scherpereel A, Depontieu F, Grigoriu B, et al: Endocan, a new endothelial marker in human sepsis. Crit Care Med 2006; 34:532-537
5. Bechard D, Gentina T, Delehedde M, et al: Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 2001; 276: 48341-48349
6. Sarrazin S, Adam E, Lyon M, et al: Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 2005 Sep 13; [Epub ahead of print]
7. Bechard D, Meignin V, Scherpereel A, et al: Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res 2000; 37:417-425
8. Bechard D, Scherpereel A, Hammad H, et al: Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 2001; 167:3099-3106
9. van Dissel JT, van Langevelde P, Westendorp RG, et al: Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351:950-953